Supernus Pharmaceuticals Net Worth 2011-2024 | SUPN

Interactive chart of historical net worth (market cap) for Supernus Pharmaceuticals (SUPN) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Supernus Pharmaceuticals net worth as of May 02, 2025 is $1.84B.
Sector Industry Market Cap Revenue
Medical MED-GENERIC DRG $1.839B $0.662B
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) IL $18.357B 6.72
Dr Reddy's Laboratories (RDY) IN $11.687B 22.29
BridgeBio Pharma (BBIO) US $7.324B 0.00
Bausch Health Cos (BHC) CA $2.003B 1.45
Amphastar Pharmaceuticals (AMPH) US $1.164B 7.04
Taysha Gene Therapies (TSHA) US $0.529B 0.00
Personalis (PSNL) US $0.367B 0.00
Assembly Biosciences (ASMB) US $0.108B 0.00
Sol-Gel Technologies (SLGL) IL $0.020B 0.00
Evoke Pharma (EVOK) US $0.005B 0.00
Teligent (TLGT) US $0.000B 0.00